BIOLASE Names Current Director Alexander K. Arrow President and Chief Operating Officer

BIOLASE Names Current Director Alexander K. Arrow President and Chief Operating 
IRVINE, CA -- (Marketwired) -- 06/07/13 --  BIOLASE, Inc. (NASDAQ:
BIOL), the world's leading manufacturer and distributor of dental
lasers, announced today that medical technology executive and current
Director Alexander K. Arrow, M.D., has been named President and Chief
Operating Officer. Dr. Arrow will report directly to Federico
Pignatelli, the Chairman and Chief Executive Officer. 
Dr. Arrow, 42, has served on BIOLASE's Board of Directors since July
2010, and the Board of cardiovascular start-up Rindex Medical since
June 2011. Most recently he served as the Chief Medical and Strategic
Officer of Circuit Therapeutics, Inc., a Stanford-affiliated
neurological device company seeking to commercialize
optogenetics-enabled products, since July 2012. From 2007 through
2012, Dr. Arrow was the Chief Financial Officer of Arstasis, Inc., a
115-employee cardiology device manufacturer. From 2002 to 2007, Dr.
Arrow headed medical technology equity research at the global
investment bank Lazard, where he provided research coverage on
BIOLASE, among other companies. Dr. Arrow also spent two years as
Chief Financial Officer of the Patent & License Exchange, Inc. He was
awarded an M.D. from Harvard Medical School in 1996 and a B.A. in
Biophysics, magna cum laude, from Cornell University in 1992. 
"I couldn't be more excited about the tremendous prospects for
BIOLASE," said Dr. Arrow. "My first task will be to expand the
proportion of dentists who are enthusiastic owners of BIOLASE's
products and make our revolutionary WaterLase technology the standard
of care for patients."  
"The dental market alone makes BIOLASE an extraordinary growth
opportunity. When coupled with the potential for our unique
tissue-ablating laser technology through strategic partnerships in
orthopedics, ophthalmology, ENT, podiatry, and dermatology, all with
FDA clearances and broad patent protection, I have one of the most
exciting jobs in all of med tech," concluded Dr. Arrow. 
Federico Pignatelli, Chairman and Chief Executive Officer, said, "I
am extremely pleased to have the knowledgeable and energetic Dr.
Arrow take on the role of President and COO. I appreciate the medical
technology manage
ment experience that he brings to the Company and I
know he will contribute greatly to BIOLASE's continued revenue
growth, improved financial performance, and marketplace recognition." 
About BIOLASE, Inc.
 BIOLASE, Inc. is a biomedical company that
develops, manufactures, and markets innovative lasers in dentistry
and medicine and also markets and distributes high-end 2D and 3D
digital imaging equipment and CAD/CAM intraoral scanners; products
that are focused on technologies that advance the practice of
dentistry and medicine. The Company's proprietary laser products
incorporate over 350 patented and patent-pending technologies
designed to provide biologically clinically superior performance with
less pain and faster recovery times. Its imaginative products provide
cutting-edge technology at competitive prices to deliver the best
results for dentists and patients. BIOLASE's principal products are
revolutionary dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications, and a full line of dental imaging equipment. BIOLASE(R)
has sold more than 22,500 lasers. Other laser products under
development address ophthalmology and other medical and consumer
For updates and information on WaterLase(R) and laser dentistry, find
BIOLASE online at, Facebook at, Twitter at,
Pinterest at, LinkedIn at, Instagram at and YouTube at  
BIOLASE(R) and WaterLase(R) are registered trademarks of BIOLASE,
For further information, please contact: 
Michael Porter 
Porter, LeVay & Rose, Inc. 
Press spacebar to pause and continue. Press esc to stop.